Strain-Counterstrain Treatment of Piriformis Pain
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this investigator-initiated study is to provide an efficient and non-invasive treatment option for pain caused by the piriformis muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2021
CompletedFirst Posted
Study publicly available on registry
August 26, 2021
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
September 1, 2027
April 24, 2026
April 1, 2026
1 year
August 11, 2021
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Algometer - Change in pressure pain threshold
Objective improvement in pressure/pain threshold
Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.
Secondary Outcomes (2)
Change in Visual Analog Scale
Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.
Change in Oswestry Disability Index
Before first treatment and after second treatment. Each treatment is 1-2 weeks apart (anticipated).
Study Arms (2)
Piriformis Strain-Counterstrain
EXPERIMENTALThe treatment group will receive strain-counterstrain for the piriformis muscle.
Hamstring Strain-Counterstrain
SHAM COMPARATORThe sham group will receive strain-counterstrain treatment for the hamstring muscle.
Interventions
Participant will lay prone on table with affected leg close to edge of table. Piriformis muscle tender point is identified and palpated. Then patient leg is passively moved off table and passive hip flexion, abduction, and possible internal/external rotation is added to reduce tender point by 70% or more. This is done passively. This position is held for 90 seconds and then participant is passively returned back to neutral prone position with leg on table. Tender point is palpated again to reassess for change in pain (using subjective visual analog scale). An algometer is also used pre and post to assess objective change in pressure pain threshold.
Eligibility Criteria
You may qualify if:
- to 65 years of age
- Tender point (or trigger point) in piriformis muscle determined by physical exam
You may not qualify if:
- Less than 45 degrees of active hip flexion, less than 5 degrees of active hip internal rotation or less than 30 degrees of active hip external rotation, on side of affected piriformis
- Unable to lay prone
- Non-English speaker
- Inability to attend 2 sessions within the same month
- Active cancer
- Pregnant
- Diagnosis of lumbar radiculopathy
- Greater than grade 1 lumbar spondylolisthesis
- Presence of lumbar region Pars Defect
- Receiving massage, acupuncture, chiropractic treatments, osteopathic treatments during study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University Health
Loma Linda, California, 92350, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mickey Lui
Loma Linda University Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participant will not know the true positioning for strain counterstrain treatment of piriformis muscle versus hamstring muscle.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2021
First Posted
August 26, 2021
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share